Fig. 6. Peripheral blood CD45⁺CD33^lowCD11b^dim myeloid cell frequency, and IL-6, IL-8, and arginase I levels correlate with GC tumor progression and decreased patient survival.

Peripheral blood (a) CD45⁺CD33^lowCD11b^dim myeloid cell percentages (b) arginase I concentration, (c) IL-6 concentration, and (d) IL-8 concentration were measured and categorized by patient TNM stage. Kaplan-Meier plots were calculated for overall patient survival according to (a) median peripheral blood CD45⁺CD33^lowCD11b^dim myeloid cell percentage (9.2%) or (b) median arginase I concentration (7.52 ng/ml) or (c) median IL-6 concentration (22.37 pg/ml) or (d) median IL-8 concentration (61.61 pg/ml). *p < 0.05; **p < 0.01; n.s, p > 0.05. ARG arginase I